| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |